Being the dermal absorption formulation which has with the medicine content pressure sensitive adhesive layer where the backing and the said backing one side are provided at least on the surface, other than acid attaching salting where medicine content pressure sensitive adhesive layer, adhesion base and paronosetoron or acid attaching salting and the carbon count the direct saturation alcohol of 6 which that pharmacy are allowed - 12, carbon count the direct unsaturated alcohol of 10 - 22, carbon count the divergence alcohol and carbon count of 10 - 22 - 15 annular alcohol at least the aliphatic alcohol of 1 where it is selected kinds and, consists of the constitution component which is made necessary from the group where consist of 10, paronosetoron or that is allowed pharmacyThe constitution component is the component which the carboxyl group the possession is not done, the dermal absorption formulation.支持体と、該支持体の少なくとも一方面上に設けられた薬物含有感圧接着剤層とを備える経皮吸収製剤であって、薬物含有感圧接着剤層は、粘着基剤と、パロノセトロン又はその薬学的に許容される酸付加塩と、炭素数6~12の直鎖飽和アルコール、炭素数10~22の直鎖不飽和アルコール、炭素数10~22の分岐アルコール及び炭素数10~15の環状アルコールからなる群より選択される少なくとも1種の脂肪族アルコールと、を必須とする構成成分からなり、パロノセトロン又はその薬学的に許容される酸付加塩以外の構成成分は、カルボキシル基を有しない成分である、経皮吸収製剤。
